Treating Children with Aplastic Anemia

Video

Dr. Timothy Olson, a pediatric hematologist at Children's Hospital of Philadelphia, discusses the most current thinking on the treatment of children with aplastic anemia.

Dr. Timothy Olson, a pediatric hematologist at Children's Hospital of Philadelphia, discusses the most current thinking on the treatment of children with aplastic anemia. Topics include an overview of aplastic anemia, treatment options for children, and the effects of treatment on patients.

Related Videos
Mikkael Sekeres, MD:
Lynn Malec, MD: FVIII Therapy Improves Levels in Pediatric Patients with Hemophilia A
Lynn Malec, MD:
Guy Young, MD: More Advancement for Subcutaneous Hemophilia Treatments
Guy Young, MD
Margaret Ragni, MD: Liver Abnormalities in Hemophilia A Gene Therapy Require Close Monitoring
Nadia Ovchinsky, MD: Odevixibat's Phase 3 Data and Potential for Alagille Syndrome
Nadia Ovchinsky, MD: IBAT Inhibitors for Alagille Syndrome
Related Content

Olezarsen Benefits Familial Chylomicronemia Syndrome in Phase 3 Balance Trial

September 26th 2023

Rare Disease Report Podcast: FDA Reviews Combination Therapy for Pompe Disease

October 28th 2022

FDA Approves Pozelimab (Veopoz) as First Treatment for CHAPLE Disease

August 18th 2023

Rare Disease Report Podcast: Newborn Screening Awareness and Novel Diagnostic Tool

October 10th 2022

FDA Approves Palovarotene for Fibrodysplasia Ossificans Progressiva

August 17th 2023

Apellis Reviewing Retinal Vasculitis Cases in Pegcetacoplan-Treated GA Patients

July 31st 2023

Olezarsen Benefits Familial Chylomicronemia Syndrome in Phase 3 Balance Trial

September 26th 2023

Rare Disease Report Podcast: FDA Reviews Combination Therapy for Pompe Disease

October 28th 2022

FDA Approves Pozelimab (Veopoz) as First Treatment for CHAPLE Disease

August 18th 2023

Rare Disease Report Podcast: Newborn Screening Awareness and Novel Diagnostic Tool

October 10th 2022

FDA Approves Palovarotene for Fibrodysplasia Ossificans Progressiva

August 17th 2023

Apellis Reviewing Retinal Vasculitis Cases in Pegcetacoplan-Treated GA Patients

July 31st 2023

Olezarsen Benefits Familial Chylomicronemia Syndrome in Phase 3 Balance Trial

September 26th 2023

Rare Disease Report Podcast: FDA Reviews Combination Therapy for Pompe Disease

October 28th 2022

FDA Approves Pozelimab (Veopoz) as First Treatment for CHAPLE Disease

August 18th 2023

Rare Disease Report Podcast: Newborn Screening Awareness and Novel Diagnostic Tool

October 10th 2022

FDA Approves Palovarotene for Fibrodysplasia Ossificans Progressiva

August 17th 2023

Apellis Reviewing Retinal Vasculitis Cases in Pegcetacoplan-Treated GA Patients

July 31st 2023
© 2023 MJH Life Sciences

All rights reserved.